CD81
Basic information
Region (hg38): 11:2376177-2397802
Previous symbols: [ "TAPA1" ]
Links
Phenotypes
GenCC
Source:
- common variable immunodeficiency (Supportive), mode of inheritance: AD
- immunodeficiency, common variable, 6 (Limited), mode of inheritance: Unknown
- immunodeficiency, common variable, 6 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency, common variable, 6 | AR | Allergy/Immunology/Infectious | Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious; Renal | 20237408 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD81 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 51 | 57 | ||||
missense | 71 | 71 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 11 | 14 | 25 | |||
non coding | 52 | 20 | 74 | |||
Total | 0 | 0 | 76 | 103 | 26 |
Variants in CD81
This is a list of pathogenic ClinVar variants found in the CD81 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-2377192-T-C | Benign (Nov 10, 2018) | |||
11-2377547-G-A | Uncertain significance (Apr 01, 2018) | |||
11-2377558-G-C | CD81-related disorder | Likely benign (Sep 08, 2023) | ||
11-2377560-A-G | Uncertain significance (Oct 04, 2023) | |||
11-2377572-A-G | Uncertain significance (Jan 19, 2023) | |||
11-2377575-G-A | Uncertain significance (Mar 04, 2022) | |||
11-2377576-C-T | Likely benign (Oct 17, 2022) | |||
11-2377586-C-T | Likely benign (Mar 20, 2021) | |||
11-2377597-C-G | Likely benign (Nov 27, 2023) | |||
11-2377598-T-C | Uncertain significance (May 23, 2023) | |||
11-2377609-C-T | Likely benign (Aug 30, 2023) | |||
11-2377619-A-G | Uncertain significance (Jun 23, 2022) | |||
11-2377626-C-G | Likely benign (Nov 23, 2021) | |||
11-2377629-CG-C | Benign (Aug 24, 2023) | |||
11-2390138-G-A | Benign (Jun 19, 2021) | |||
11-2390306-C-T | Benign (Nov 10, 2018) | |||
11-2390392-C-A | Likely benign (Mar 17, 2023) | |||
11-2390393-T-A | Likely benign (Jul 16, 2023) | |||
11-2390397-C-T | Benign (Jan 29, 2024) | |||
11-2390399-C-T | Benign (Jan 19, 2024) | |||
11-2390403-C-T | Likely benign (Nov 25, 2023) | |||
11-2390414-G-A | Uncertain significance (Jun 05, 2022) | |||
11-2390416-C-T | Uncertain significance (May 08, 2022) | |||
11-2390423-C-A | Benign (Jan 12, 2024) | |||
11-2390423-C-T | Likely benign (Nov 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD81 | protein_coding | protein_coding | ENST00000263645 | 8 | 21243 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.918 | 0.0815 | 125029 | 0 | 1 | 125030 | 0.00000400 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.806 | 110 | 137 | 0.806 | 0.00000858 | 1545 |
Missense in Polyphen | 39 | 67.17 | 0.58062 | 719 | ||
Synonymous | -2.04 | 79 | 59.0 | 1.34 | 0.00000437 | 445 |
Loss of Function | 3.01 | 1 | 12.4 | 0.0804 | 5.42e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play an important role in the regulation of lymphoma cell growth. Interacts with a 16-kDa Leu-13 protein to form a complex possibly involved in signal transduction. May act as the viral receptor for HCV.;
- Disease
- DISEASE: Immunodeficiency, common variable, 6 (CVID6) [MIM:613496]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. {ECO:0000269|PubMed:20237408}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- B cell receptor signaling pathway - Homo sapiens (human);Malaria - Homo sapiens (human);Hepatitis C - Homo sapiens (human);B Cell Receptor Signaling Pathway;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;BCR;Regulation of Complement cascade;Complement cascade;Beta1 integrin cell surface interactions;Alpha4 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.392
Intolerance Scores
- loftool
- 0.219
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.142
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.660
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd81
- Phenotype
- hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- activation of MAPK activity;cell surface receptor signaling pathway;protein localization;cell population proliferation;positive regulation of cell population proliferation;regulation of complement activation;positive regulation of B cell proliferation;receptor internalization;regulation of protein stability;positive regulation of 1-phosphatidylinositol 4-kinase activity;positive regulation of transcription by RNA polymerase II;viral entry into host cell;receptor-mediated virion attachment to host cell;positive regulation of peptidyl-tyrosine phosphorylation;regulation of immune response;protein localization to lysosome;cellular response to low-density lipoprotein particle stimulus;positive regulation of protein catabolic process in the vacuole;regulation of cell motility
- Cellular component
- immunological synapse;plasma membrane;integral component of plasma membrane;focal adhesion;membrane;basolateral plasma membrane;vesicle;extracellular exosome
- Molecular function
- virus receptor activity;integrin binding;protein binding;MHC class II protein complex binding;transferrin receptor binding